help button home button JAMIA Bigger figures
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

First published August 21, 2007 as JAMIA PrePrint; doi:10.1197/jamia.M2232
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
M2232v1
14/6/731    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hinrichsen, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinrichsen, V. L.
J Am Med Inform Assoc. 2007;14:731-735. DOI 10.1197/jamia.M2232.
© 2007 American Medical Informatics Association


Application of Information Technology

Using Electronic Medical Records to Enhance Detection and Reporting of Vaccine Adverse Events

Virginia L. Hinrichsen, MS, MPHa,*, Benjamin Kruskal, MDb, Megan A. O’Brien, MPHc, Tracy A. Lieu, MD, MPHd, Richard Platt, MD, MSce Vaccine Safety Datalink Team

a Department of Ambulatory Care and Prevention
b Harvard Medical School
c Harvard Pilgrim Health Care
d Department of Pediatrics
e Harvard Vanguard Medical Associates.

* Correspondence: Virginia L. Hinrichsen, Dept. of Ambulatory Care and Prevention, 133 Brookline Ave. Boston, MA 02215 (Email: Virginia_Hinrichsen{at}HarvardPilgrim.org).

Received for publication: 07/31/06; accepted for publication: 07/26/07.

We implemented an automated vaccine adverse event surveillance and reporting system based in an ambulatory electronic medical record to improve underreporting and incomplete reporting that prevails in spontaneous systems. This automated system flags potential vaccine adverse events for the clinician when a diagnosis is entered, prompts clinicians to consider the vaccine as a cause of the condition, and facilitates reporting of suspected adverse events to the Vaccine Adverse Event Reporting System (VAERS).

During five months, a total of 33,420 vaccinations were administered during 14,466 encounters. There were 5,914 follow-up contacts by vaccinees within 14 days of the vaccination visits; 686 (11.6%) generated an alert. Clinicians submitted VAERS reports for 23 of these (0.69 per 1,000 vaccine doses), which is almost 6 times the dose-based reporting rate to VAERS.1 Clinician surveys indicated that it took a minimal amount of time to respond to the alerts. Of those who felt that an alert corresponded to an actual vaccine adverse event, the majority used the reporting feature to file a VAERS report.

We believe that elicited surveillance via real time prompts to clinicians holds substantial promise. By coupling simplified reporting with the initial prompt, clinicians can consider and report a vaccine adverse event electronically in a few moments during the office visit.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Medical Informatics Association.